2023 was a more than successful year, enabling us to consolidate our leadership in the gluten-free sector.
Under the leadership of Hannes Berger, CEO of Dr. Schär, we ended the 2023 financial year on a positive note with global sales of €561 million (+16,8% compared to 2022), confirming the growth trend for both domestic and international markets. This is an accomplishment achieved also focusing on the local productions. This not only makes it easier for us to source our products and meet our customers’ needs in a timely manner, but also limits our CO2 emissions.